PPMO's as therapeutic modulators for myotonic dystrophy type 1

PPMO's as therapeutic modulators for myotonic dystrophy type 1

Bibliografske podrobnosti
Main Authors:	Holland, A, Varela, M, Klein, A, Raz, R, Arzumanov, A, Gait, M, Wood, M
Format:	Conference item
Izdano:	Wiley 2018

Podobne knjige/članki

Proteomic evaluation of Pip6a-PMO treatment for myotonic dystrophy type 1
od: Holland, A, et al.
Izdano: (2018)

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
od: Klein, AF, et al.
Izdano: (2019)

Application of antisense conjugates for the treatment of myotonic dystrophy type 1
od: Stoodley, J, et al.
Izdano: (2023)

Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy
od: Liubov V. Gushchina, et al.
Izdano: (2022-12-01)

Cardiac manifestations in myotonic dystrophy type 1
od: A. G. Klementieva, et al.
Izdano: (2024-09-01)

Myotonic dystrophy type 2
od: G. E. Rudenskaya, et al.
Izdano: (2017-02-01)

Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression
od: Irene González-Martínez, et al.
Izdano: (2023-12-01)

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC).
od: Ashizawa, T, et al.
Izdano: (2000)

Peptide-conjugated PMOs for the treatment of myotonic dystrophy
od: Stoodley, J, et al.
Izdano: (2022)

Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
od: Jie Liu, et al.
Izdano: (2021-11-01)

Neurocognitive disorder in Myotonic dystrophy type 1
od: Stefan Winblad, et al.
Izdano: (2024-05-01)

Benefits of aerobic exercise in myotonic dystrophy type 1
od: Samuel J. Mackenzie, et al.
Izdano: (2022-05-01)

Responsiveness of outcome measures in myotonic dystrophy type 1
od: Kirsten L. Knak, et al.
Izdano: (2020-08-01)

Application of CRISPR-Cas9-mediated genome editing for the treatment of myotonic dystrophy type 1
od: Marsh, S, et al.
Izdano: (2020)

Molecular Pathology of Myotonic Dystrophy Type 1 in Iceland
od: E. G. Hallgrímsdóttir, et al.
Izdano: (2024-10-01)

Structural white matter networks in myotonic dystrophy type 1
od: Maud van Dorst, et al.
Izdano: (2019-01-01)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
od: Francesca Bosè, et al.
Izdano: (2019-09-01)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
od: Josef Finsterer, et al.
Izdano: (2017-04-01)

Clarification on “Myotonic Dystrophy Type 1 – An Atypical Presentation”
od: Joydeep Mukherjee, et al.
Izdano: (2024-10-01)

Myotonic dystrophy type 1: one case report
od: WU Xu⁃ling, et al.
Izdano: (2023-08-01)

Imaging in Myotonic Dystrophy Type 1 – Case Reports
od: Jurgen Bielen, et al.
Izdano: (2016-10-01)

Clinical characteristics of different forms of myotonic dystrophy type 1
od: E. K. Erokhina, et al.
Izdano: (2023-06-01)

Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
od: Overby, SJ, et al.
Izdano: (2022)

Cell membrane integrity in myotonic dystrophy type 1: implications for therapy.
od: Anchel González-Barriga, et al.
Izdano: (2015-01-01)

Congenital Myotonic Dystrophy
od: J Gordon Millichap
Izdano: (1987-09-01)

Senescence plays a role in myotonic dystrophy type 1
od: Mikel García-Puga, et al.
Izdano: (2022-10-01)

Cognitive and emotional disturbances in adult patients with myotonic dystrophy type 1
od: E. K. Erokhina, et al.
Izdano: (2024-05-01)

Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1
od: Josef Finsterer, et al.
Izdano: (2021-01-01)

A case of myotonic dystrophy type 1 with paternal history of clinical worsening
od: S. A. Kurbatov, et al.
Izdano: (2017-02-01)

Recurrent pulmonary embolism complicated with myotonic dystrophy type 1
od: Hiraku Sedogawa, et al.
Izdano: (2024-09-01)

4 Hypogammaglobulinemia and infection risk in myotonic dystrophy type 1
od: James Triplett, et al.
Izdano: (2024-08-01)

A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
od: Ji-Hyun Choi, et al.
Izdano: (2018-09-01)

Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
od: Yuka Urata, et al.
Izdano: (2020-02-01)

Myotonic Dystrophy Type 1 with Syringomyelia in a Young Patient
od: Xiao-Lin Yu, et al.
Izdano: (2016-01-01)

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
od: Stefan Hintze, et al.
Izdano: (2018-10-01)

Pulmonary thromboembolism in a patient with myotonic dystrophy type 1
od: Joong-Yang Cho, et al.
Izdano: (2012-01-01)

Epidemiology of myotonic dystrophy type 1 in the population of central Serbia
od: Mladenović Jelena, et al.
Izdano: (2005-01-01)

Cardiac involvement in myotonic dystrophy
od: Koroush Khalighi, et al.
Izdano: (2015-02-01)

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
od: Garazi Labayru, et al.
Izdano: (2018-01-01)

Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
od: Hilton-Jones, D, et al.
Izdano: (2012)